Roche NimbleGen Q3 Sales Rise 22 Percent on Rising Sequence Capture, Array CGH Demand

According to a company spokesperson, the growth was primarily driven across the two application areas by sales of its SeqCap EZ Exome offering for target enrichment as well as its CGX cytogenetic arrays.